Ticker Details
Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$4.26B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.72 | 3.31%
Avg Daily Range (30 D):	$5.32 | 4.33%
Avg Daily Range (90 D):	$4.11 | 3.54%

Institutional Daily Volume
Avg Daily Volume:	.17M
Avg Daily Volume (30 D):	1.37M
Avg Daily Volume (90 D):	.83M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	54

Institutional Trades
Total Institutional Trades:	1,228
Avg Institutional Trade:	$4.39M
Avg Institutional Trade (30 D):	$5.22M
Avg Institutional Trade (90 D):	$5.93M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$8.09M
Avg Closing Trade (30 D):	$15.94M
Avg Closing Trade (90 D):	$13.11M
Avg Closing Volume:	122.45K

News

Jun 4, 2026 @ 2:13 AM Celcuity Inc. Announces Pricing of Upsized Public ... Source: Na

Apr 27, 2026 @ 10:18 PM Why Celcuity Stock Popped on Monday Source: Eric Volkman

Mar 27, 2026 @ 12:05 AM Why Celcuity Stock Popped Today Source: Eric Volkman

Mar 13, 2026 @ 2:28 PM Inside One Fund's $170 Million Bet on a Biotech St... Source: Jonathan Ponciano

Mar 9, 2026 @ 9:42 PM Celcuity Announces Publication of Results from PIK... Source: Celcuity Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.91	$-.97	$-.98
Diluted EPS	$-3.91	$-.97	$-.98
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-192.89M	$-52.84M	$-50.97M
Operating Income / Loss	$-186.57M	$-50.51M	$-49.2M
Cost of Revenue
Net Cash Flow	$128.71M	$-20.51M	$91.45M
PE Ratio